Karin Kast

3.9k total citations
52 papers, 1.1k citations indexed

About

Karin Kast is a scholar working on Genetics, Oncology and Cancer Research. According to data from OpenAlex, Karin Kast has authored 52 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Genetics, 21 papers in Oncology and 18 papers in Cancer Research. Recurrent topics in Karin Kast's work include BRCA gene mutations in cancer (30 papers), Cancer Genomics and Diagnostics (11 papers) and Ovarian cancer diagnosis and treatment (9 papers). Karin Kast is often cited by papers focused on BRCA gene mutations in cancer (30 papers), Cancer Genomics and Diagnostics (11 papers) and Ovarian cancer diagnosis and treatment (9 papers). Karin Kast collaborates with scholars based in Germany, United States and Netherlands. Karin Kast's co-authors include Rita K. Schmutzler, Nina Ditsch, Kerstin Rhiem, Pauline Wimberger, Alfons Meindl, Alfons Meindl, Marion Kiechle, Christoph Engel, Kerstin Rhiem and Dominic Varga and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Karin Kast

42 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karin Kast Germany 15 556 400 394 361 168 52 1.1k
Meredith Mills United States 16 971 1.7× 539 1.3× 454 1.2× 300 0.8× 382 2.3× 32 1.5k
Angela George United Kingdom 17 596 1.1× 307 0.8× 412 1.0× 564 1.6× 144 0.9× 60 1.2k
Paweł Blecharz Poland 15 287 0.5× 309 0.8× 234 0.6× 358 1.0× 288 1.7× 72 1.0k
Luna Kadouri Israel 19 412 0.7× 248 0.6× 530 1.3× 401 1.1× 107 0.6× 56 1.1k
Monika Graeser Germany 13 355 0.6× 462 1.2× 337 0.9× 445 1.2× 131 0.8× 46 929
Lizet E. van der Kolk Netherlands 17 359 0.6× 146 0.4× 308 0.8× 322 0.9× 337 2.0× 33 1.3k
Julian M. Hess United States 8 319 0.6× 542 1.4× 896 2.3× 274 0.8× 228 1.4× 13 1.3k
Edenir Inêz Palmero Brazil 20 564 1.0× 522 1.3× 751 1.9× 610 1.7× 275 1.6× 78 1.4k
Amit Sud United Kingdom 15 285 0.5× 161 0.4× 361 0.9× 244 0.7× 211 1.3× 37 962
Tamar Hamburger Israel 19 246 0.4× 214 0.5× 397 1.0× 444 1.2× 132 0.8× 55 911

Countries citing papers authored by Karin Kast

Since Specialization
Citations

This map shows the geographic impact of Karin Kast's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Kast with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Kast more than expected).

Fields of papers citing papers by Karin Kast

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Kast. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Kast. The network helps show where Karin Kast may publish in the future.

Co-authorship network of co-authors of Karin Kast

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Kast. A scholar is included among the top collaborators of Karin Kast based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Kast. Karin Kast is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schoffer, Olaf, Pauline Wimberger, Michael Gerken, et al.. (2024). Treatment in Certified Breast Cancer Centers Improves Chances of Survival of Patients with Breast Cancer. Geburtshilfe und Frauenheilkunde. 84(2). 153–163. 6 indexed citations
2.
Schoffer, Olaf, Pauline Wimberger, Michael Gerken, et al.. (2024). Die Behandlung in zertifizierten Brustkrebszentren verbessert die Überlebenschancen von Patient*innen mit Brustkrebs. Senologie - Zeitschrift für Mammadiagnostik und -therapie. 21(2). 121–131. 1 indexed citations
3.
Kast, Karin, et al.. (2024). Phenotype analysis of families with TP53 germline variants at the Center for Familial Breast and Ovarian Cancer, Cologne. Cancer Medicine. 13(3). e6920–e6920. 1 indexed citations
4.
Mooij, Thea M., Anouk Pijpe, Gabe S. Sonke, et al.. (2022). Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits. JNCI Journal of the National Cancer Institute. 114(4). 540–552. 7 indexed citations
5.
Fischer, Christine, Hans‐Peter Sinn, Nicola Dikow, et al.. (2021). Breast cancer characteristics and surgery among women with Li‐Fraumeni syndrome in Germany—A retrospective cohort study. Cancer Medicine. 10(21). 7747–7758. 11 indexed citations
6.
Seitz, S., et al.. (2021). Hormone replacement therapy in BRCA mutation carriers and risk of ovarian, endometrial, and breast cancer: a systematic review. Journal of Cancer Research and Clinical Oncology. 147(7). 2035–2045. 26 indexed citations
8.
Wimberger, Pauline, et al.. (2019). Patient-Reported Satisfaction after Prophylactic Operations of the Breast. Breast Care. 14(4). 217–223. 9 indexed citations
9.
Kast, Karin, Pauline Wimberger, & Norbert Arnold. (2018). Changes in classification of genetic variants in BRCA1 and BRCA2. Archives of Gynecology and Obstetrics. 297(2). 279–280. 7 indexed citations
10.
Becker, Kerstin, Luisa Mackenroth, Andreas Rump, et al.. (2017). Spectrum of genetic variants of BRCA1 and BRCA2 in a German single center study. Archives of Gynecology and Obstetrics. 295(5). 1227–1238. 16 indexed citations
11.
Kast, Karin, Olaf Schoffer, Theresa Link, et al.. (2017). Trastuzumab and survival of patients with metastatic breast cancer. Archives of Gynecology and Obstetrics. 296(2). 303–312. 23 indexed citations
12.
Schubert, Barbara, Michael Krämer, Felicitas Lenz, et al.. (2017). Benefits and risks of a percutaneous endoscopic gastrostomy (PEG) for decompression in patients with malignant gastrointestinal obstruction. Supportive Care in Cancer. 25(9). 2849–2856. 19 indexed citations
13.
Kast, Karin, et al.. (2016). Prevalence of Lynch syndrome in unselected patients with endometrial or ovarian cancer. Archives of Gynecology and Obstetrics. 294(6). 1299–1303. 4 indexed citations
14.
Wolf, Christine, Alexander Rapp, Nicole Berndt, et al.. (2016). RPA and Rad51 constitute a cell intrinsic mechanism to protect the cytosol from self DNA. Nature Communications. 7(1). 11752–11752. 132 indexed citations
15.
Wobus, Manja, Tobias Dittrich, Karin Kast, et al.. (2014). Breast carcinoma cells modulate the chemoattractive activity of human bone marrow-derived mesenchymal stromal cells by interfering with CXCL12. International Journal of Cancer. 136(1). 44–54. 27 indexed citations
16.
Meindl, A, Kerstin Rhiem, Christoph Engel, et al.. (2013). Clinical course and genetics of hereditary breast and ovarian cancer. mediaTUM (Technical University of Munich).
17.
Goeckenjan, Maren, Karin Kast, W. Distler, & Pauline Wimberger. (2013). Fertilitätsreduktion durch Chemotherapie in der gynäkologischen Onkologie. Der Gynäkologe. 46(9). 608–615.
18.
Kast, Karin & Norbert Arnold. (2012). Gendiagnostik bei familiären Tumoren. Der Gynäkologe. 45(1). 28–34.
19.
Kast, Karin, Mechthild Krause, Markus K. Schuler, et al.. (2012). Late onset Li-Fraumeni Syndrome with bilateral breast cancer and other malignancies: case report and review of the literature. BMC Cancer. 12(1). 217–217. 17 indexed citations
20.
Kast, Karin, Teresa Neuhann, Heike Görgens, et al.. (2012). Germline truncating-mutations in BRCA1 and MSH6 in a patient with early onset endometrial cancer. BMC Cancer. 12(1). 531–531. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026